InDevR Launches Expert Services to Address Vaccine Development Challenges

InDevR Inc., a global leader in vaccine analytical tools and method development, has introduced Expert Services to assist vaccine manufacturers overcome development hurdles and expedite the validation of seasonal vaccines and novel biotherapeutics.

Expert Services is InDevR's new solution aimed at advancing vaccine development. With over two decades of experience in custom vaccine assay development, Expert Services leverages InDevR's sophisticated assay development tools and curated reagents. It combines the reliability and precision of the VaxArray platform with custom-tailored services to meet clients' unique needs with accuracy and efficiency.

Kathy Rowen, CEO of InDevR, emphasized that Expert Services is a comprehensive solution designed to be adaptive, offering bespoke testing solutions along with their proven assays to address the unique challenges in vaccine development and validation.

InDevR's initiative is aimed at organizations looking for innovative solutions to minimize resource usage and time to market, providing a vital resource in the complex vaccine and drug product development fields. Michael Schrader, CEO of Vaxess, highlighted the benefits of InDevR's reagent kits for their development team, saving significant time and resources.

With Expert Services, InDevR strengthens its position in the vaccine validation industry and continues its dedication to supporting the development of safe and effective vaccines and therapeutics.